Lotus Resources Limited

Lotus Resources presents a compelling investment in the uranium sector, leveraging Kayelekera's accelerated restart and Letlhakane's large-scale potential to deliver cashflow and growth. Kayelekera's US$50M initial capex delivers 2.4Mlbs pa steady-state production, with 23Mlb Ore Reserves and offtake contracts securing margins above C1 costs through 2029 (3.5-3.8Mlbs fixed-price escalated). Letlhakane's updated Scoping Study outlines 3Mlbs pa over 10 years (29Mlb LOM) at US$41/lb opex, with PFS targeted for 2H 2026 following 70% acid reduction via two-stage leaching.​

Positioned in Malawi and Botswana—Africa's top mining jurisdiction per Fraser Institute—Lotus benefits from proximity to infrastructure, grid power upgrades, and acid plant rebuilds to optimize costs. With 60% uncontracted production in early years shifting to market-linked pricing, the company captures upside in a market facing supply deficits and nuclear expansion (31 countries targeting triple capacity by 2050).​

Amid tightening utility coverage and producer downgrades (e.g., Kazatomprom, Cameco), Lotus offers leverage to sustained higher prices while de-risking via Kayelekera cashflow funding Letlhakane advancement.​

Lotus Resources is led by a highly experienced team with proven track records in uranium production, African project delivery, and capital markets. Managing Director Greg Bittar brings 25 years across investment banking, funding, M&A, and project studies (ex-Morgan Stanley), guiding strategy from developer to producer. Non-Executive Chairman Michael Bowen offers 40+ years in resources law, M&A, and capital raisings, with current roles at Genesis Minerals (ASX: GMD) and Emerald Resources (ASX: EMR).​

Chief Operating Officer Michael da Costa, a mining engineer and ex-CEO of Murray Roberts' global mining business, oversees African operations including Anglo Platinum and Lonmin projects. Chief Financial Officer Hayden Bartrop delivers 20+ years in resources finance across Australia, Africa, and North America (ex-Barrick Gold, Iluka). Uranium specialists include Processing Manager Sarel Malan (15+ years at Paladin, CGN Swakop) and Sales Exec Dr. Robert Rich (30 years advising US utilities on nuclear fuel procurement).​

Non-Executive Directors Leanne Heywood (35+ years, ex-Rio Tinto executive) and Simon Hay (ex-CEO Galaxy Resources, Leo Lithium) provide governance, operations, and growth expertise. This board and executive lineup ensures disciplined execution, ESG focus, and stakeholder alignment.​

Lotus Resources is executing a clear growth plan anchored by Kayelekera's ramp-up to 2.4Mlbs pa in Q1 2026, funding Letlhakane's PFS in 2H 2026 and regional exploration for mine life extensions. Optimizations like owner-operator mining, grid connection, acid plant (240t/day capacity), and TSF lifts enhance Kayelekera economics, while Letlhakane infill drilling (US$1.8M, 12,000m RC) upgrades Inferred to Indicated resources.​

The offtake strategy balances fixed contracts for margin protection with market-linked upside (60% uncontracted early years), supported by US$64M liquidity and potential US$30M facilities. Dual-asset synergy positions Lotus for 5.5Mlbs pa potential, capitalizing on uranium fundamentals: supply gaps post-2030, US policy for nuclear growth, and decarbonization demand.​

Strategic flexibility includes partnerships for Letlhakane scaling (e.g., staged 2Mlbs pa expandable to 3-4Mlbs), ensuring low-risk progression in favorable jurisdictions while maximizing shareholder value.​

As of 30 September 2025, Lotus Resources maintains a robust balance sheet with A$96.7M cash (US$64M), no debt, and US$102M liquidity including equipment/working capital facilities. Kayelekera's US$50M restart capex is complete, with deferred optimizations (grid, acid plant) and FY26 spend covered; Letlhakane studies add ~US$2M.​

Kayelekera delivers steady-state AISC US$45/lb over 10 years (2.4Mlbs pa), with life-of-mine including 4% Inferred from stockpiles. Letlhakane Scoping Study projects US$465M initial capex, US$41/lb opex for 3Mlbs pa (preliminary, 25% Inferred). Offtake covers C1 costs via 3.5-3.8Mlbs fixed contracts to 2029, preserving upside.​

A$65M recent raise extends runway for ramp-up, inventory, and growth, positioning Lotus for cashflow generation and debt optimization amid strong uranium pricing.​

Lotus Resources proactively manages key risks in uranium development and production. Commodity price volatility is mitigated by fixed offtake covering C1 costs and market-linked exposure, with robust economics at current US$86/lb term prices. Restart delays at Kayelekera were avoided through on-budget execution; ramp-up risks are addressed via experienced operators (ex-Paladin, BHP) and owner-mining.​

Funding needs are covered by US$64M cash and facilities, with Curzon US$15-30M loan negotiations ongoing. Regulatory/permitting risks in Malawi/Botswana are low given secured licenses, MDA, and ESIA; ESG focus includes community agreements. Exploration uncertainties (Inferred resources) are tackled via targeted drilling at Letlhakane and Kayelekera extensions.​

Operational hazards like acid supply are resolved via on-site plant rebuilds; forex/political risks are standard for tier-1 African jurisdictions, backed by experienced African team.​

Lotus Resources Limited stands at the forefront of uranium supply growth, with Kayelekera's production restart and Letlhakane's world-class resource delivering scale in a tightening market. Robust 165Mlb resources, low-capex path, and secured offtake position the company for multi-asset cashflow amid nuclear renaissance.​

Experienced leadership, financial strength (US$64M cash, no debt), and optimizations like acid reduction ensure de-risked advancement to 5.5Mlbs pa potential. As supply deficits widen and prices firm, Lotus offers investors leveraged exposure to uranium's structural bull case, combining near-term production with long-life growth in premier jurisdictions.​